[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fmpZx4jtVPo7gwLrxtfP3h5ZpgkIk-Ue7RfroT72dLYI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":46,"rows":53},"The Miriam Hospital",[4],182,false,24,19,28317,3,171,[14,17,20,22,24,27,30,33],{"name":15,"count":16},"Obesity",62,{"name":18,"count":19},"Overweight",10,{"name":21,"count":19},"Overweight and Obesity",{"name":23,"count":19},"HIV",{"name":25,"count":26},"Weight Loss",9,{"name":28,"count":29},"Smoking Cessation",6,{"name":31,"count":32},"HIV Infections",5,{"name":34,"count":32},"Pediatric Obesity",[36,41],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT06704204","Long-acting Injectable Antiretroviral Treatment to Improve HIV Treatment Among Justice-involved Persons Being Released to the Community","2025-07-31","The first FDA-approved LAI ART regimen includes an integrase inhibitor, cabotegravir (CAB), and a non-nucleoside reverse transcriptase inhibitor, rilpivirine (RPV) combined 4 wks",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT06494488","Differential Thrombogenesis by EPA and DHA Mediated by HDL","2027-08-01","EPA",[47,48,49,50,51,52],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[54,81,99,120,147,171,198,223,248,272,307],{"intervention":45,"totalTrials":55,"cells":56},1,{"EARLY_PHASE1":57,"PHASE1":70,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":79},{"trials":58,"activeCount":55,"soonestReadout":44},[59],{"nctId":42,"briefTitle":43,"status":60,"phases":61,"primaryCompletion":44,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":68},"RECRUITING",[47],"2028-03-31","2025-07-10",80,[66,67],"Lipid Metabolism Disorders","Hypertriglyceridemia",[45,69],"DHA",{"trials":71,"activeCount":72},[],0,{"trials":74,"activeCount":72},[],{"trials":76,"activeCount":72},[],{"trials":78,"activeCount":72},[],{"trials":80,"activeCount":72},[],{"intervention":69,"totalTrials":55,"cells":82},{"EARLY_PHASE1":83,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":97},{"trials":84,"activeCount":55,"soonestReadout":44},[85],{"nctId":42,"briefTitle":43,"status":60,"phases":86,"primaryCompletion":44,"completion":62,"start":63,"enrollment":64,"conditions":87,"interventions":88},[47],[66,67],[45,69],{"trials":90,"activeCount":72},[],{"trials":92,"activeCount":72},[],{"trials":94,"activeCount":72},[],{"trials":96,"activeCount":72},[],{"trials":98,"activeCount":72},[],{"intervention":40,"totalTrials":55,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":111},{"trials":102,"activeCount":72},[],{"trials":104,"activeCount":72},[],{"trials":106,"activeCount":72},[],{"trials":108,"activeCount":72},[],{"trials":110,"activeCount":72},[],{"trials":112,"activeCount":55,"soonestReadout":39},[113],{"nctId":37,"briefTitle":38,"status":114,"phases":115,"primaryCompletion":39,"completion":39,"start":116,"enrollment":117,"conditions":118,"interventions":119},"NOT_YET_RECRUITING",[],"2025-02",20,[23],[40],{"intervention":121,"totalTrials":55,"cells":122},"Tranexamic acid",{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":145},{"trials":124,"activeCount":72},[],{"trials":126,"activeCount":72},[],{"trials":128,"activeCount":72},[],{"trials":130,"activeCount":72},[],{"trials":132,"activeCount":72},[133],{"nctId":134,"briefTitle":135,"status":136,"phases":137,"primaryCompletion":138,"completion":139,"start":140,"enrollment":141,"conditions":142,"interventions":144},"NCT04443920","Tranexamic Acid for Total Knee Arthroscopy","COMPLETED",[51],"2020-10-07","2021-01-08","2019-10-29",86,[143],"Blood Loss, Surgical",[121],{"trials":146,"activeCount":72},[],{"intervention":148,"totalTrials":55,"cells":149},"dutasteride",{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":156,"PHASE4":158,"NA":169},{"trials":151,"activeCount":72},[],{"trials":153,"activeCount":72},[],{"trials":155,"activeCount":72},[],{"trials":157,"activeCount":72},[],{"trials":159,"activeCount":72},[160],{"nctId":161,"briefTitle":162,"status":136,"phases":163,"primaryCompletion":164,"completion":164,"start":165,"enrollment":8,"conditions":166,"interventions":168},"NCT00752869","Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement",[51],"2012-03","2008-09",[167],"Hypogonadism",[148],{"trials":170,"activeCount":72},[],{"intervention":172,"totalTrials":55,"cells":173},"Emtricitabine \u002F Tenofovir",{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":196},{"trials":175,"activeCount":72},[],{"trials":177,"activeCount":72},[],{"trials":179,"activeCount":72},[],{"trials":181,"activeCount":72},[],{"trials":183,"activeCount":72},[184],{"nctId":185,"briefTitle":186,"status":187,"phases":188,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":193,"interventions":195},"NCT04240509","Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV Infection","UNKNOWN",[51],"2021-12-01","2021-12-31","2019-11-01",100,[31,194],"Sexually Transmitted Diseases",[172],{"trials":197,"activeCount":72},[],{"intervention":199,"totalTrials":55,"cells":200},"raltegravir",{"EARLY_PHASE1":201,"PHASE1":203,"PHASE2":205,"PHASE3":207,"PHASE4":219,"NA":221},{"trials":202,"activeCount":72},[],{"trials":204,"activeCount":72},[],{"trials":206,"activeCount":72},[],{"trials":208,"activeCount":72},[209],{"nctId":210,"briefTitle":211,"status":136,"phases":212,"primaryCompletion":213,"completion":214,"start":215,"enrollment":117,"conditions":216,"interventions":218},"NCT00887653","Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy",[50],"2012-06","2014-04","2009-05",[23,217,67,31],"Hyperlipidemia",[199],{"trials":220,"activeCount":72},[],{"trials":222,"activeCount":72},[],{"intervention":224,"totalTrials":55,"cells":225},"Fecal Microbiota Transplantation",{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":242,"PHASE4":244,"NA":246},{"trials":227,"activeCount":72},[],{"trials":229,"activeCount":72},[],{"trials":231,"activeCount":72},[232],{"nctId":233,"briefTitle":234,"status":187,"phases":235,"primaryCompletion":236,"completion":237,"start":238,"enrollment":29,"conditions":239,"interventions":241},"NCT02557685","Gut Microbiota Changes After Fecal Microbiota Transplantation",[49],"2016-03","2017-03","2015-06",[240],"Clostridium Difficile Infection",[224],{"trials":243,"activeCount":72},[],{"trials":245,"activeCount":72},[],{"trials":247,"activeCount":72},[],{"intervention":249,"totalTrials":55,"cells":250},"Ketamine",{"EARLY_PHASE1":251,"PHASE1":262,"PHASE2":264,"PHASE3":266,"PHASE4":268,"NA":270},{"trials":252,"activeCount":72},[253],{"nctId":254,"briefTitle":255,"status":187,"phases":256,"primaryCompletion":190,"completion":190,"start":257,"enrollment":117,"conditions":258,"interventions":261},"NCT04099771","Ketamine for Mood Disorders With Suicidal Ideation",[47],"2019-07-01",[259,260],"Depressive Disorder, Major","Suicidal Ideation",[249],{"trials":263,"activeCount":72},[],{"trials":265,"activeCount":72},[],{"trials":267,"activeCount":72},[],{"trials":269,"activeCount":72},[],{"trials":271,"activeCount":72},[],{"intervention":273,"totalTrials":274,"cells":275},"Nicotine patch",2,{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":284,"NA":286},{"trials":277,"activeCount":72},[],{"trials":279,"activeCount":72},[],{"trials":281,"activeCount":72},[],{"trials":283,"activeCount":72},[],{"trials":285,"activeCount":72},[],{"trials":287,"activeCount":72},[288,298],{"nctId":289,"briefTitle":290,"status":136,"phases":291,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":295,"interventions":297},"NCT01964898","Post Acute Coronary Event Smoking Study",[52],"2015-04","2013-10",65,[28,296],"Acute Coronary Syndrome",[273],{"nctId":299,"briefTitle":300,"status":136,"phases":301,"primaryCompletion":302,"completion":302,"start":303,"conditions":304,"interventions":305},"NCT01684995","Motivation and Nicotine Patch Treatment for Under-served Smokers",[52],"1999-11","1996-12",[28],[306],"nicotine patch",{"intervention":308,"totalTrials":55,"cells":309},"Dexamethasone",{"EARLY_PHASE1":310,"PHASE1":312,"PHASE2":314,"PHASE3":316,"PHASE4":318,"NA":320},{"trials":311,"activeCount":72},[],{"trials":313,"activeCount":72},[],{"trials":315,"activeCount":72},[],{"trials":317,"activeCount":72},[],{"trials":319,"activeCount":72},[],{"trials":321,"activeCount":72},[322],{"nctId":323,"briefTitle":324,"status":136,"phases":325,"primaryCompletion":326,"completion":326,"start":327,"enrollment":328,"conditions":329,"interventions":334},"NCT04445506","Short Term Corticosteroids in SARS-CoV2 Patients",[],"2020-05-31","2020-04-01",50,[330,331,332,333,308],"Corticosteroids","Covid19","SARS-CoV 2","Steroids",[308]]